Auteur M. SHAW

  Tris disponibles Ajouter le résultat à votre sélection

  Affiner la recherche

Buprenorphine compared with methadone in pregnancy: A systematic review and meta-analysis

M. KINSELLA ; L. O. E. HALLIDAY ; M. SHAW ; Y. CAPEL ; S. M. NELSON ; R. J. KEARNS | 2022
Dans Substance Use and Misuse (Vol.57, n°9, 2022) Article : Périodique

INTRODUCTION: Illicit opioid use in pregnancy is associated with adverse maternal, neonatal, and childhood outcomes. Opioid substitution is recommended, but whether methadone or buprenorphine is the optimal agent remains unclear. METHODS: We se[...]

Plus d'info

Ajouter à la sélection

Lien externe

Gender of physicians with substance use disorders: clinical characteristics, treatment utilization, and post-treatment functioning

MC GOVERN M. P. ; D. H. ANGRES ; M. SHAW ; RAWAL P. | 2003
Périodique

ENGLISH : Gender has emerged as an important variable in both the course and treatment of substance-use disorders. This study examines the role of gender in a sample of physicians (n=73) treated for substance-use disorders. Pilot data gathered[...]

Plus d'info

Ajouter à la sélection

Smoking and ill health: does lay epidemiology explain the failure of smoking cessation programs among deprived populations?

D. LAWLOR ; S. FRANKEL ; M. SHAW ; EBRAHIM S. | 2003
Dans American Journal of Public Health (Vol.93 n°2, 2003) Article : Périodique

Plus d'info

Ajouter à la sélection